PT  - JOURNAL ARTICLE
AU  - Elhakeem, Ahmed
AU  - Frysz, Monika
AU  - Soares, Ana G
AU  - Bell, Joshua A
AU  - Cole, Tim J
AU  - Heron, Jon
AU  - Howe, Laura D
AU  - Sebert, Sylvain
AU  - Tilling, Kate
AU  - Timpson, Nicholas J
AU  - Lawlor, Deborah A
TI  - Evaluation and comparison of nine growth- and development-based measures of pubertal timing
AID  - 10.1101/2023.06.12.23290796
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.06.12.23290796
4099  - http://medrxiv.org/content/early/2023/06/20/2023.06.12.23290796.short
4100  - http://medrxiv.org/content/early/2023/06/20/2023.06.12.23290796.full
AB  - Puberty timing is fundamentally part of life-course health. Yet, little is known about the value of different measures of pubertal timing, particularly in males. We used a population-based cohort to examine nine measures of pubertal age (n=8,500), identifying development of pubic hair in males (12.6y) and breasts in females (11.5y) as early indicators of puberty, and voice breaking (14.2y) and menarche (12.7y) as late indicators. All measures showed evidence of positive phenotypic intercorrelations (e.g., r=0.49: male genitalia and pubic hair ages), and positive genetic intercorrelations. A genetic risk score (GRS) for age at menarche associated positively with all other measures (e.g., difference in female peak height velocity age per SD higher GRS: 0.24y, 95%CI: 0.21 to 0.26), as did GRS for voice breaking age (e.g., difference in male axillary hair age: 0.11y, 0.07 to 0.15). We illustrate the value of different pubertal age measures and their use in life-course research.Competing Interest StatementDAL reported grants from national and international government and charity funders, Roche Diagnostics, and Medtronic Ltd for work unrelated to this publication. The other authors report no conflicts.Clinical Protocols https://osf.io/3qndg/ Funding StatementThis study has received funding from the European Union Horizon 2020 research and innovation programme under grant agreement No. 874739 (LongITools). AE and DAL receive part of their salary from the European Union Horizon 2020 research and innovation program under grant agreement No. 101021566 (ART-HEALTH). AE, MF, AGS, JAB, JH, LDH, KT, NJT, and DAL work in a Unit that receives funds from the University of Bristol and UK Medical Research Council (MC_UU_00011/1&6). DAL is a National Institute of Health Research Senior Investigator (NF-0616-10102) and is also supported by a British Hear Foundation Chair (CH/F/20/90003). The UK Medical Research Council and Wellcome (Grant ref 217065/Z/19/Z), and the University of Bristol provide core support for ALSPAC. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. AE had full access to all the data in the study and takes responsibility for the integrity of the data and accuracy of the data analysis.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData used in this study were from the ALSPAC birth cohort.Researchers interested in accessing ALSPAC data used in this study will need to submit a research proposal (https://proposals.epi.bristol.ac.uk/) for consideration by the ALSPAC Executive Committee (managed access). http://www.bristol.ac.uk/alspac/